NCT05598268
A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors. treatment 1 / 2 recruiting NCT03907852
Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer treatment 1 / 2 active_not_recruiting NCT04300244
Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma treatment 2 active_not_recruiting NCT06477419
A Study of Sacituzumab Govitecan in People With Mesothelioma treatment 2 recruiting NCT04115111
Diadem to Investigate the Activity and Safety of Durvalumab treatment 2 completed NCT06581549
Immune Microenvironment and Gene Expression Profiling in Mesothelioma No drug interventions Not Available Not Available recruiting NCT05500508
Oral AMXT 1501 Dicaprate in Combination with IV DFMO treatment 1 / 2 active_not_recruiting NCT04214015
A Pilot Study to Explore the Role of Gut Flora in Metastatic Mesothelioma No drug interventions Not Available Not Available unknown_status NCT04996017
Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso) treatment 3 unknown_status NCT03475953
A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors treatment 1 / 2 recruiting NCT03054298
CAR T Cells in Mesothelin Expressing Cancers No drug interventions treatment 1 completed NCT03760575
Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM) treatment 1 recruiting NCT05278975
Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma treatment 1 / 2 recruiting NCT05451849
A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer treatment 1 / 2 active_not_recruiting NCT06451536
Ga-68 FAPI PET Before Immunotherapy No drug interventions diagnostic Not Available recruiting NCT04400539
The IMmunotherapy Pleural 5-ALA PDT treatment 2 recruiting NCT04287829
Pembrolizumab Plus Lenvatinib In Second Line and Third Line Malignant Pleural mesotheLioma Patients treatment 2 active_not_recruiting NCT05304208
dENdritic Cell Therapy Combined With SURgEry in Mesothelioma No drug interventions treatment 1 recruiting NCT00037817
Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies treatment 1 completed NCT05538806
TTFields in General Routine Clinical Care in Patients with Pleural Mesothelioma Study No drug interventions Not Available Not Available recruiting NCT05714553
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours treatment 1 / 2 recruiting NCT06155279
Induction Chemo+immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma (CHIMERA Study) treatment 2 not_yet_recruiting NCT06362369
A Study of Oral 7HP349 (Alintegimod) in Combination with Ipilimumab Followed by Nivolumab Monotherapy treatment 1 / 2 recruiting NCT00165503
Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate diagnostic 2 terminated NCT02414945
TILs & Low-Dose IL-2 Therapy Following Cyclophosphamide and Fludarabine in Pleural Mesothelioma Patients treatment 1 / 2 completed NCT04430842
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S No drug interventions treatment 1 completed NCT00165516
Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate treatment 2 completed NCT01160458
Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy treatment 2 completed NCT00895648
Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma treatment 2 terminated NCT02707666
A Pilot Window-Of-Opportunity Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Resectable Malignant Pleural Mesothelioma treatment 1 terminated NCT05930665
Study of Cadonilimab Combined With Bevacizumab and Standard Chemotherapy as First Line Therapy in Unresectable Pleural Mesothelioma treatment 2 recruiting NCT04040231
Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma treatment 1 active_not_recruiting NCT02585362
Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program No drug interventions supportive_care Not Available completed NCT05086692
A Beta-only IL-2 ImmunoTherapY Study treatment 1 / 2 recruiting NCT05910112
Prospective Data Collection on Clinical, Radiological and Patient Reported Outcomes After Pleural Intervention No drug interventions Not Available Not Available recruiting NCT02899195
Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma treatment 2 completed NCT00859495
Trimodal Lung-Sparing Treatment of Pleural Mesothelioma treatment 2 terminated NCT03210298
International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) No drug interventions Not Available Not Available unknown_status NCT04914897
A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202) treatment 2 active_not_recruiting NCT05077111
A Comparative Study Between Regional Anesthesia in Thoracoscopes and the Conventional General Anesthesia No drug interventions supportive_care 4 unknown_status NCT04324437
eRAPID: Online Symptom Reporting in Lung Cancer No drug interventions other Not Available completed NCT04334759
DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma treatment 3 active_not_recruiting NCT04823741
Molecular, Pathologic Intra Tumoral Heterogeneity in Malignant Pleural Mesothelioma No drug interventions Not Available Not Available recruiting NCT05337735
A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers treatment 2 suspended NCT06410625
Evaluation of Response by FLT PET in Mesothelioma No drug interventions diagnostic Not Available recruiting NCT06416930
Study of Cadonilimab Combined With Chemotherapy in Recurrent / Refractory Pleural Mesothelioma treatment 2 not_yet_recruiting NCT02588131
A Study of Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1) treatment 2 unknown_status NCT04106973
Mesothelioma Early Detection by VOCs No drug interventions Not Available Not Available terminated NCT05628376
TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO No drug interventions Not Available Not Available recruiting NCT00299962
Gene Therapy for Pleural Malignancies treatment 1 completed NCT04042480
A Study of SGN-CD228A in Advanced Solid Tumors No drug interventions treatment 1 terminated NCT00165555
Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma treatment 1 completed